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Editorial
Education makes people take 
their medication: myth or 
maxim?
It is a source of frustration to many clinicians: you 
know what the patient’s problem is, you know 
that effective and safe treatment is available, 
you’ve explained the disease and its causative 
mechanisms, the treatment and its principles, and 
the importance of taking the controller medication 
daily, you’ve prescribed this highly effective therapy 
and you’ve approached the patient with respect 
and patience, yet somehow the patient does 
not take the medication. When this patient has 
another exacerbation, you know it could have been 
prevented by following your advice and taking the 
medication.
When we, as clinicians, are faced with such 
a nonadherence scenario, our default mode is 
to repeat the message that we delivered when 
we first saw the patient and provided self-
management education: we stress, once again, 
that it is really important that the patient takes 
their daily controller medication. Apparently, many 
healthcare professionals believe that such repeated 
education makes people take their medication. In 
this editorial, we argue that this is a myth. There 
is extensive high-quality evidence that education, 
on its own, does not promote adherence to daily 
controller medication in patients with a chronic 
disease [1, 2]. There is also evidence to support 
an effective alternative approach: healthcare 
professionals can do a lot to promote adherence 
in their patients through shared decision making 
[1, 3, 4]. The key to promoting adherence through 
education is not in what message we convey, not 
in the content of information we provide, but in 
how we provide it. In this sense, the statement in 
the title is also a maxim: education can certainly 
promote adherence, if performed effectively. 
Therefore, we also review the evidence on the 
principles of effective patient education which 
healthcare professionals can use to promote 
adherence.
In this review, most of the evidence and 
recommendations that we provide on adherence 
and adherence-promoting communication 
strategies comes from paediatric studies and our 
experience in paediatric care. In this setting, parents 
are primarily responsible for making the decisions 
on the treatment of their child’s medical condition, 
and most communication about the patient’s 
adherence to daily controller therapy is conducted 
between adults, i.e. the healthcare professionals 
and the child’s parents or caregivers. This may help 
to understand why the principles of adherence 
and nonadherence, and the communication 
strategies healthcare providers can employ to 
promote adherence in their patients, are the same 
in paediatric and adult care. To improve readability 
of the remaining text, we use the word “patient” 
to include the people responsible for the patient’s 
medication taking behaviour, irrespective of the 
patient’s age.
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Nonadherence: the 
most common cause of 
uncontrolled chronic disease
Although the guideline-based daily controller 
medication prescribed for chronic diseases such 
as asthma shows clinically relevant beneficial 
effects in clinical trials and meta-analyses, 
we regularly encounter patients in whom this 
treatment does not seem to work as well [5]. 
In patients with such uncontrolled disease, 
the guidelines prompt us to step up treatment, 
increase the dose, add more drugs, or screen for 
relevant comorbidity affecting disease control. 
Despite their strong evidence base in cases of 
true therapy-resistant disease, such interventions 
are not likely to be effective as long as the major 
underlying cause of poor disease control remains 
unaddressed: nonadherence to follow treatment 
recommendations [6–8].
In 2003, the World Health Organization (WHO) 
summarised the evidence, available at that time, 
on the scope and the impact of nonadherence [4]. 
The WHO described it as a “worldwide problem 
of striking magnitude”, with mean adherence 
rates in chronic disease of 50%, meaning that the 
average patient with a chronic disease only takes 
half of the medication doses prescribed to them. It 
described the consequences of this poor adherence 
as “poor health outcomes and increased healthcare 
costs”, and it cited a systematic review concluding 
that “increasing the effectiveness of adherence 
interventions may have a far greater impact on the 
health of the population than any improvement in 
specific medical treatments” [9].
Sadly, this situation has not improved much 
since. Nonadherence in chronic respiratory 
disease remains common, even in patients with 
very severe disease. For example, when asthma 
nurses visited the homes of children referred to a 
national UK centre because of problematic severe 
asthma, medication was either absent or out of 
date in 23% of cases [10]. The average adherence 
rate of daily inhaled corticosteroids (ICS) therapy 
in children with asthma is still around 50% [3, 




The most widely used theoretical model to describe 
adherence and self-management behaviour in 
chronic conditions is the so-called common-sense 
model (figure 1) [12–14]. According to this model, 
patients develop their own cognitive representations 
of their illness, including beliefs about causes of 
the illness, the impact the illness will have on their 
lives, how long the illness will last, and whether or 
not it is controllable or curable. Together with the 
emotional responses to the threat of the illness, 
these representations are known as “illness 
perceptions”. Illness perceptions are shaped by 
early experiences with being sick, the response from 
caregivers and family on sickness, and by accounts 
of illness in the lay press and on the Internet. Thus, 
illness perceptions are much more influenced by 
cultural, social and psychological factors than 
by “objective” medical severity or demographic 
characteristics. The patient’s illness perceptions 
strongly determine the patient’s perceived need 
of medication, which is one of the main drivers of 
adherence [15].
On the other side of the model, driving the 
perceived concerns about medication, medication 
beliefs comprise doubts about the necessity of 
medication to maintain or promote health and 
concerns about the potential adverse effects 
of treatment. Both quantitative and qualitative 
studies show strong associations between these 
medication beliefs and medication adherence [13, 
14]. Patients consciously or unconsciously balance 
the perceived need and perceived concerns of 
medication, and the tip of this balance determines 
the degree of adherence [13]. The word perceived 
is of key importance – it is the patient’s perceived 
need and concerns of medication that drives their 
adherence behaviour, not the objective medical 
need or adverse effects of medication based on 
evidence and guidelines. This is one of the reasons 
why simply repeating the objective medical need 
of taking medication daily is so ineffective: [1, 2] it 
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Figure 1 The common-sense model of medication adherence behaviour. Data from [12, 13].
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Main forms of nonadherence
The many factors that affect adherence relate to 
healthcare systems and healthcare providers (e.g. 
short consultation time, lack of healthcare providers’ 
knowledge on adherence), social and economic 
issues (e.g. illiteracy, poverty and lack of support 
systems), therapy itself (e.g. complexity of treatment 
and side-effects), patient issues (e.g. self-efficacy 
and psychosocial stress) and condition-related 
issues (e.g. severity of symptoms and comorbidity) 
[4]. Within this complex interplay of factors 
associated with adherence, three different types of 
nonadherence can be distinguished (table 1).
Unwitting nonadherence relates to patients 
who do not understand the rationale or logic of 
the treatment (e.g. do not know the difference 
between brown and blue inhalers), mix up different 
treatments (e.g. use the blue inhaler daily and 
the brown as needed), or misunderstand dosing 
regimens (e.g. take medication once every 4 days 
instead of four times a day). This may be affected 
by patients’ cognitive abilities, language barriers 
and individual’s health literacy.
Unwitting adherence can be addressed by 
education on the rationale of treatment, e.g. 
the difference between daily controller therapy 
and reliever therapy. However, the documented 
ineffectiveness of such education [1, 2] suggests 
that unwitting nonadherence, although it does occur 
occasionally, is not the main cause of nonadherence.
Erratic (or chaotic) nonadherence relates either 
to the complexity of the treatment itself or to the 
chaos of the patient’s life. Failing to understand a 
complex treatment schedule could also be classified 
as a form of unwitting nonadherence, and this 
should be amenable for targeted education. The 
chaos of a patient’s life, however, is less easily 
adjustable. In families dealing with serious issues 
like poverty and debt, psychiatric disease, addiction, 
violence, unemployment or relationship problems, 
these issues can take priority over taking medication 
every day [16, 17]. Repeating or providing education 
on disease mechanisms and rationale of treatment, 
or on the importance of taking medication daily, will 
have little effect on these patients. Helping these 
patients to successfully self-manage their disease 
requires tailored support after careful elucidation 
of factors contributing to nonadherence [16, 17].
Research suggests that deliberate (or intelligent) 
nonadherence is the most common type of 
nonadherence, with a strong association of illness 
perceptions and medication beliefs to adherence 
rates [12, 13, 15]. Many patients choose to 
ignore the healthcare professional’s advice to take 
medication daily. Some of them believe that they 
know more about the best treatment for them than 
the healthcare provider does [18], others respect the 
professional’s knowledge and skills but are convinced 
that there are other, personal or social, considerations 
which take priority over medical knowledge in 
deciding whether daily controller therapy is good 
for them (or their child). For example, all parents we 
interviewed about their view on ICS therapy for their 
child with asthma disliked or even hated the idea of 
having to give daily medication to their child, and 
they used strong words like “poison” and “chemical 
rubbish” to describe these medication [19].
Assessing adherence 
and its determinants
Being able to assess adherence reliably is important 
because it allows the clinician to understand to what 
degree poor adherence may play a role in a patient 
with uncontrolled disease. In addition, knowledge of 
the type of nonadherence in an individual patient is 
a prerequisite to be able to provide targeted support 
to improve adherence and, consequently, improve 
disease control.
The accuracy of different methods to assess 
adherence varies considerably (table 2). Patient or 
parent self-report consistently overestimates true 
adherence, partly because of social desirability 
bias [3, 20]. The use of anonymous adherence 
questionnaires may partly overcome this problem, 
but adherence assessed by validated questionnaires 
such as the medication adherence report scale still 
considerably overestimates adherence assessed 
objectively by electronic methods [22]. Physicians 
and asthma nurses also overestimate their patients’ 
adherence [3]. Pharmacy refill rates only assess 
whether the patients have picked up the medication, 
not whether they have used it [3, 21]. Weighing 
or using the dose counters on returned inhalers 
is more accurate, but still open to “dumping” and 
falsification [3, 21]. Pharmacological techniques 
(assessing drug levels in blood or urine) can be 
technically challenging (given the low systemic 
availability of drugs like ICS), are costly and require 
repeated blood or urine samples. Because ICS 
therapy reduces exhaled nitric oxide fraction (FeNO) 
levels, FeNO has been proposed as a potential ICS 
adherence marker. However, we found a poor 
association between FeNO levels and adherence in 
children with asthma followed up for 1 year [24].
Table 1 The differential diagnosis of nonadherence
Type of nonadherence Characteristics
Unwitting Misunderstand dosing regimen, fail to 
understand rationale for treatment
Erratic (or chaotic) Difficulty following treatment because of its 
complexity or because of chaos of patients’ 
lives
Deliberate (or intelligent) Deliberately decide that perceived concerns 
of medication outweigh its perceived need
Adapted from [4] and [16].
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Because of their high accuracy, electronic 
monitoring devices are considered to be the 
gold standard of adherence assessment [3, 
26]. These devices record the exact date and 
time of each actuation of the inhaler device 
(in asthma and other diseases using inhaled 
medication), allowing accurate calculation of 
adherence as a percentage of the prescribed 
dosages of medication [26]. Adherence rates 
>80% are needed to achieve optimal asthma 
control [27, 28].
Although electronic adherence monitoring is 
recommended in research studies and in cohorts of 
children with problematic severe asthma [3, 11], it 
is too cumbersome and costly to serve as a standard 
adherence screening tool in the large majority of 
patients with mild-to-moderate chronic asthma or 
other respiratory conditions.
None of the adherence assessment methods 
(table 2) provides the healthcare professional with 
a reliable tool to distinguish between the three 
most common types of adherence (table 1). 
Taking a history remains the most important tool 
to obtain information about unwitting or erratic 
nonadherence [16]. Illness and medication beliefs, 
the main drivers of deliberate nonadherence, can 
be assessed by validated questionnaires [29, 30]. 
In the following sections, we will discuss how these 
can also be explored by talking to patients, and 
how this conversation can be used to support the 
patient in achieving optimal adherence.
Shared decision making
As discussed above, almost all patients have 
strong illness and medication beliefs which 
play a major role in determining adherence to 
daily controller therapy. Most patients will not 
express such concerns spontaneously, either out 
of embarrassment or because they do not want 
to disappoint the healthcare professional who 
evidently does their best to help them. Whether 
or not patients are willing to disclose these 
adherence-hindering perceptions depends on the 
patient’s trust in their physician [31, 32]. Such 
trust develops gradually, and is determined more 
strongly by relational and communicational issues 
than by the physician’s medical competence [33].
Taking a medical history through talking to 
patients and their families has always been a 
doctor-centred approach, focusing on obtaining 
the medical information needed to support 
clinical reasoning and make a diagnosis [34]. This 
reflects the long domination of the paternalistic 
decision-making model in medicine [35]. In the 
past decades, the increasing recognition of the 
importance of the patient’s perspective on their 
medical problems and the treatment for these 
problems, with their impact on adherence and 
other health-related behaviours, has paved the 
way for another, more collaborative approach to 
talking to patients and making decisions in medical 
consultations. This approach has become known 
as shared decision making [36, 37]. The evidence 
supporting shared decision making is considerable 
(box 1). The justification for the shared decision 
model primarily comes from the ethical perspective 
of respecting patients’ autonomy [37]. Almost all 
patients expect and prefer to be involved in the 
decision making process in consultations with a 
healthcare professional, and prefer to collaborate 
with their physician [39]. More generally, shared 
decision making also appeals to the basic human 
need of being seen, respected and taken seriously 
[37]. In studies comparing shared decision making 
with more traditional doctor-centred approaches 
in medical consultations, shared decision making 
is associated with patients being more satisfied 
with the decision making process, the consultation 
as a whole and the healthcare professional [37, 
38]. In addition, they are more satisfied with the 
decision taken, which increases their likelihood 
of following through with the actions related to 
the decision and, hence, with their adherence 
to the agreed-upon treatment [3, 38]. In shared 
decisions, patients also tend to go for less invasive 
and exhaustive treatment options than with 
paternalistic decision making, which may have 
an impact on healthcare costs as well [37].
Despite its strong justification and accumulating 
evidence for its beneficial effects on relevant patient 
outcomes, shared decision making is applied in 
clinical practice to a limited extent only [37]. We 
recently showed that although most physicians 
preferred shared decision making, they commonly 
reverted to paternalistic decision making, primarily 
because they felt the patient was incapable of being 
meaningfully involved in the decision at hand [40]. 
Although many physicians thought they already 
performed shared decision making, they had a 
limited view of the steps involved in this process, 
and they hardly ever made clear that a decision 
had to be made or invited the patient to express 
their views on what mattered to them in making 
Table 2 Different methods of assessing adherence
Method Accuracy [Ref.]
Self-report Highly inaccurate [11, 20, 21]
Validated anonymous questionnaire Highly inaccurate [11, 22]
Physician or asthma nurse 
assessment
Highly inaccurate [3]
Pharmacy refill rate Inaccurate [3, 21]






Exhaled nitric oxide measurement Inaccurate [24]
Electronic monitoring Highly accurate [3, 21, 25]
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the decision [40]. This is in agreement with earlier 
findings that healthcare providers ask for caregivers’ 
input on the asthma management plan for their 
children in only 9% of cases [41].




The considerable body of evidence supporting a 
patient-centred approach, in particular shared 
decision making, as a means to improve patients’ 
adherence to the proposed therapy is reviewed in 
detail elsewhere [3, 42–44]. The communicative 
strategies involved in patient-centred consultations 
are summarised in box 2.
The opening of a consultation sets the scene 
for the atmosphere in the consultation, and the 
patient’s trust in the clinician [45, 46]. Rapport 
building and trust are essential in improving 
adherence [32, 48]. Setting a collaborative 
agenda can be promoted by asking patients and 
their families what they wish to discuss during 
the consultation, instead of starting with the 
ubiquitous question “how are you?” (which hardly 
ever generates meaningful information) or asking 
doctor-centred questions related to diagnosis or 
management, e.g. questions used to assess asthma 
control [49].
The first step towards successful shared decision 
making is to inform the patient that a decision has 
BOX 1 Evidence supporting the use of shared decision making in consultations [33, 37, 38]
Justification
• Patients prefer humane, personalised care
• The importance of patients’ autonomy allowing them to be actively involved in decisions 
impacting their health
• Patients prefer to collaborate with their physician
• Basic human need to be taken seriously and listened to respectfully
Effects
• Increased patient satisfaction with decision-making process and with consultation
• Increased satisfaction with decision being taken, less decisional regret
• Patients choose less exhaustive and invasive treatment options
• Increased adherence
BOX 2 Communicative strategies healthcare professionals can employ to promote adherence 
[3, 33, 45, 46, 47]
Start of the consultation
• Rapport building
• Collaborative agenda setting
• Aligning expectations
Eliciting the patient’s perspective
• Explore illness and medication beliefs respectfully
• Invite patient to share their views and preferences on treatment and outcomes
• Ask for potential barriers in following through with the treatment plan
Show empathy
• Foster the relationship with patients and their families throughout the consultation
• Remain mindful of own thoughts, feelings and distractions
• Do not prescribe one therapy, but present options with pros and cons
• Acknowledge patient cues with empathic responses
• Provide information only at request or with the patient’s permission
End of the consultation
• Co-create a plan, respecting and supporting patient’ preferences as much as possible
• Invite patient and family to ask questions
• Seek explicit agreement on the treatment plan
• Remain flexible to adjust plan according to patient’ preferences
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to be made, and that the healthcare professional 
values the patient’s views and preferences as 
important input in this process [36, 37]. As 
discussed above, most patients will not volunteer 
their illness and medication beliefs, but are willing 
to discuss them if the physician respectfully asks 
them to express their views and feelings regarding 
the medication, and explores these with “curious 
pursuit” [45]. This will generate important 
information on the potential role of deliberate 
nonadherence. Similarly, although patients tend 
to be reluctant in volunteering information about 
barriers to adherence like poverty, chaotic family 
routines, or psychiatric illness (factors related to 
chaotic nonadherence), most are willing to disclose 
them to an interested and empathic listener [16, 
50]. Empathic and attentive listening will foster 
the relationship and build trust in consultations 
[33]. Conversely, reprimanding patients for not 
achieving the desired level of disease control or 
not taking the medication as prescribed increases 
patients’ anxiety to come to the consultation, 
decreases trust in the healthcare professional, 
and reduces the effects of the education being 
provided [50].
Even if guidelines for the patient’s medical 
problem show a strong preference for a certain 
therapy (e.g. ICS for persistent asthma), there is 
always the option of not applying this therapy. 
In view of the strong resistance patients express 
against medication in general [19], we have 
stopped using the word “prescribing” when 
discussing treatment, preferring to present the 
treatment as a proposed option that can be 
chosen or not. In weighing the pros and cons of 
such proposed treatment, both medical arguments 
and the patient’s personal views and preferences 
should be taken into account [3, 37]. Providing 
information in manageable chunks, only at the 
patient’s request, or after obtaining the patient’s 
consent to provide it, helps in enhancing the 
patient’s motivation to listen to and process the 
education provided [51–53].
Shared creation of an agreed course of action 
can help to ensure that the treatment proposed 
aligns with the patient’s views and preferences 
[45, 46], and increases the likelihood of the 
patient following through with the treatment 
plan. This can be further supported by asking 
the patient for their explicit agreement with the 
treatment plan, and with their confidence in being 
able to follow it [53].
Practical tips to perform 
shared decision making 
and improve adherence 
in consultations
Although specific training helps in implementing 
shared decision making in clinical practice [54, 
55], the tips presented in box 3 may help to get 
started in everyday consultations to move towards 
more patient-centred care through shared decision 
making consultations and promote adherence.
Studies in paediatric and adult patients with 
asthma have shown high adherence to daily 
controller therapy when the approaches presented 
in boxes 2 and 3 are taken [27, 56, 57]. For example, 
in our cohort of children with persistent asthma 
followed up for 1 year, the median adherence 
rate was 84% [27], the highest adherence rate 
ever reported in a study in patients with a chronic 
disease. We and others also showed that such high 
adherence was associated with excellent asthma 
control [8, 28, 58], confirming the impact of 
interventions promoting adherence, as predicted 
by the WHO in 2003 [4].
Conclusions
“Education makes people take their treatment” 
is both a myth and a maxim. Although education 
is needed to allow patients to understand the 
rationale and logic of treatment, education on its 
own does not make patients take their treatment 
as intended. However, there are methods to use 
education in such a way that it does promote 
adherence. Patients will be more likely to 
understand and accept health education when 
healthcare professionals take a patient-centred 
approach, encourage the patient to share their 
views and preferences on the treatment, and use 
these to come to a shared treatment decision. 
Studies have shown that shared decision making 
improves adherence and, consequently, disease 
control.
BOX 3 Practical tips to improve adherence in everyday consultations
• Ask patients what they want to discuss in the consultation
• Emphasise that you feel it is important to hear the patient’s views and preferences
• Ask patients specifically about their illness and medication beliefs and their barriers to follow 
treatment recommendations
• Listen attentively to what they have to say, respond respectfully and empathically
• Provide information and education only at request or after obtaining permission
• Propose treatment rather than prescribing it
• Seek explicit agreement with the shared treatment decision
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